Shareholder Alert: The Ademi Firm investigates whether Integral Ad Science is obtaining a Fair Price for its Public Shareholders

Core Points - The Ademi Firm is investigating IAS for potential breaches of fiduciary duty and other legal violations related to its transaction with Novacap [1][2] - Shareholders of IAS are set to receive $10.30 per share in a deal valued at approximately $1.9 billion, with insiders benefiting significantly from change of control arrangements [2] - The transaction agreement restricts competing offers for IAS by imposing a substantial penalty if a competing bid is accepted, raising concerns about the board's fiduciary duties to shareholders [2]